Maximus Reports Fiscal Year 2022 Third Quarter Results

Rhea-AI Summary

Maximus (NYSE: MMS) reported a revenue decline of $118 million for Q3 FY2022, totaling $1.13 billion, impacted by a $413 million reduction in COVID-19 response work. Despite this, organic growth in the U.S. Federal Services Segment and a pipeline of signed contracts totaling $4.02 billion highlight future growth potential. Diluted EPS stood at $0.51, affected by an $11.7 million write-down. Full-year guidance remains unchanged for revenue at $4.6 billion, while EPS is projected between $2.85 and $3.05. A quarterly dividend of $0.28 per share will be paid on August 31, 2022.

Positive

• Year-to-date signed contracts total $4.02 billion, indicating strong demand.
• Normalized organic growth in U.S. Services Segment of nearly 40%, indicating robust performance in core work.
• Diluted EPS guidance revised upward to $3.95 to $4.15 adjusting for amortization of intangible assets.

Negative

• Revenue decreased by $118 million compared to the prior year, reflecting the decline in COVID-19 response work.
• Operating margin decreased from 11.2% to 4.8%, showcasing profitability challenges.
• Write-down of $11.7 million negatively impacted earnings by $0.14 per share.

- Awards and Strong Pipeline Support Base and Drive Longer-Term Growth -

TYSONS, Va.--(BUSINESS WIRE)-- Maximus (NYSE: MMS), a leading provider of government services worldwide, reported financial results for the three and nine months ended June 30, 2022.

Highlights for the third quarter of fiscal year 2022 include:

• Revenue decreased $118 million to $1.13 billion, compared to $1.24 billion for the prior year period, which is net of a $413 million expected decline in short-term COVID-19 response work. This decrease was offset by organic growth and acquired growth from the U.S. Federal Services Segment acquisitions.
• Operating margin was 4.8%, or 6.9% adjusting for amortization of intangible assets. Diluted earnings per share were $0.51, or $0.78 adjusting for amortization of intangible assets.
• Earnings negatively impacted by a contract in Outside the U.S. Segment requiring a write-down of $11.7 million, or $0.14 of diluted earnings per share. As a result, the company is revising earnings guidance for fiscal year 2022, with earnings per share estimated to range between $2.85 and $3.05 per share, or $3.95 to $4.15 per share adjusting for amortization of intangible assets. Revenue guidance midpoint of $4.6 billion is unchanged from prior guidance with ranges tightened to between $4.55 billion and $4.65 billion.
• Year-to-date signed contract awards at June 30, 2022, totaled $4.02 billion and contracts pending (awarded but unsigned) totaled $476 million.
• A quarterly cash dividend of $0.28 per share payable on August 31, 2022, to shareholders of record on August 15, 2022.

"Despite near-term headwinds as COVID work subsides and the Public Health Emergency (PHE) continues, Maximus is well-positioned for future growth as evidenced by our strong new work awards and pipeline, and capacity to take on anticipated volume expansion in our core programs," shared Bruce Caswell, President and Chief Executive Officer. "Our recently refreshed strategic plan sharpens our focus while expanding our addressable market substantially. Already, we see early points on the board in the form of wins related to our Future of Health and Technology Services growth pillars."

Caswell continued, "While near term pandemic-related disruptions remain out of our control, I am pleased with how we’ve taken control in other areas, advanced our capabilities, and positioned for future organic growth, some of which has been years in the making. As evidence of this, for the first time we were recently ranked by Washington Technology as a top 20 U.S. Federal contractor by prime obligations."

Third Quarter Results

Revenue for the third quarter of fiscal year 2022 decreased $118 million to $1.13 billion, compared to $1.24 billion for the prior year period, which is net of a $413 million expected decline in short-term COVID-19 response work. The decline was offset by a combination of organic growth and acquired growth from the U.S. Federal Services Segment acquisitions. Adjusting for COVID-19 response work, normalized organic growth would be approximately 21% over the prior year period.

Operating income for the third quarter of fiscal year 2022 totaled $54.6 million yielding an operating margin of 4.8%, or 6.9% adjusting for amortization of intangible assets. This compares to an operating margin of 11.2% for the prior year period, or 12.2% adjusting for amortization. Diluted earnings per share were $0.51, or $0.78 adjusting for amortization as compared to $1.51 per share, or $1.66 adjusting for amortization, for the prior year period.

Earnings for the third quarter of fiscal year 2022 were negatively impacted by a contract in the Outside the U.S. Segment that required a write-down of $11.7 million, or $0.14 diluted earnings per share. Absent the write-down, results were in-line with the company's expectations for lower earnings caused by declines in profitable short-term COVID-19 response work and lower volumes in core programs as Medicaid redeterminations remain paused.

U.S. Services Segment

The U.S. Services Segment reported revenue of $399 million for the third quarter of fiscal year 2022 compared to $436 million reported in the prior year period. The revenue decline was due to the expected reduction in short-term COVID-19 response work. Adjusting for this work, normalized organic growth in the segment was nearly 40% driven by ramping of new core work and COVID-19 response work that has evolved into longer term work with new customers gained during the pandemic.

Operating margin for the third quarter of fiscal year 2022 was 8.0% for the segment compared to 14.3% reported for the prior year period. The lower comparative margin was in-line with company expectations due to declines in profitable, short term COVID-19 response work while the redetermination activities tied to the ongoing Public Health Emergency (PHE) remain paused.

U.S. Federal Services Segment

U.S. Federal Services Segment revenue for the third quarter of fiscal year 2022 decreased to $526 million, compared to $618 million reported for the prior year. The decline was driven by expected reductions in short term COVID-19 response work, partially offset by contributions from the acquisitions of VES and Aidvantage. Adjusting for COVID-19 response work, normalized organic growth in the segment was approximately 6% over the prior year period.

The segment's operating margin for the third quarter of fiscal year 2022 was 10.4% which was in-line with the company's expectation. This compares to 13.9% reported for the prior year period which benefited from particularly high volumes of COVID-19 response work.

Outside the U.S. Segment

Outside the U.S. Segment revenue for the third quarter of fiscal year 2022 increased 6.0% to $201 million as compared to $190 million reported for the prior year. Results were net of a 9% currency headwind. Adjusting for COVID-19 response work, normalized organic growth in the segment was approximately 21% over the prior year period and driven primarily by ramping of the U.K. Restart Programme.

The segment realized an operating loss of $11.2 million for the third quarter of fiscal year 2022 as compared to operating income of $8.3 million for the prior year period. The loss was driven by a write-down on a project in the implementation phase. Due to higher forecasted costs, a forward loss provision was recorded this quarter, putting the contract on a path to breakeven over the remaining life.

Sales and Pipeline

Year-to-date signed contract awards at June 30, 2022, totaled $4.02 billion and contracts pending (awarded but unsigned) totaled $476 million. Awards booked in the third quarter include the previously-disclosed Indiana Eligibility Operations Support new contract, a one-year extension on the CMS Contact Center Operations contract, and various rebid wins.

The sales pipeline at June 30, 2022, was $32.5 billion (comprised of approximately $7.3 billion in proposals pending, $3.6 billion in proposals in preparation, and $21.6 billion in opportunities tracking). New work opportunities represent approximately 59% of the total sales pipeline.

Balance Sheet and Cash Flows

At June 30, 2022, cash and cash equivalents totaled $93.7 million and gross debt was $1.49 billion. The ratio of debt, net of allowed cash, to pro-forma EBITDA for the quarter ended June 30, 2022, as calculated in accordance with our credit agreement, was 2.9x.

For the third quarter of fiscal year 2022, cash from operating activities totaled $57.9 million, and free cash flow was $44.9 million. As of June 30, 2022, Days Sales Outstanding (DSO) were 70 days and within the company's typical range of 65 to 80 days. Large collections that were delayed several days were responsible for lower-than-expected cash flows and a higher DSO in the quarter.

Purchases of Maximus common stock totaled $48.0 million in the third quarter of fiscal year 2022. Subsequent to quarter-end, an additional $22.3 million of purchases have been made.

On July 8, 2022, our Board of Directors declared a quarterly cash dividend of $0.28 for each share of our common stock outstanding. The dividend is payable on August 31, 2022, to shareholders of record on August 15, 2022.

Updated Fiscal Year 2022 Guidance

The company expects revenue for fiscal year 2022 to range between $4.55 billion and $4.65 billion, yielding a $4.6 billion midpoint that is unchanged from prior guidance. Diluted earnings per share is estimated to range between $2.85 and $3.05 per share, or $3.95 to $4.15 per share adjusting for amortization of intangible assets.

Earnings guidance is revised following third quarter results inclusive of the write-down in the Outside the U.S. Segment. In addition, ramp-up costs to prepare for higher volumes anticipated in the U.S. Federal Services Segment's clinical business in fiscal year 2023, along with retention efforts for the existing staff, results in an $8 million to $10 million investment in the second half of fiscal year 2022. This contributed to pressure on fiscal year 2022 guidance but will provide a benefit to next fiscal year.

For fiscal year 2022, cash flows from operations are expected to range between $220 million and $260 million, and free cash flow to range between $170 million and $210 million. The effective income tax rate is expected to range between 25.0% and 25.5%, weighted average shares outstanding to range between 61.8 million and 62.0 million, absent further share purchase activity, and interest expense to be approximately $42 million for fiscal year 2022.

Mr. Caswell added, "As the short-term COVID-19 response work sunsets, we already see examples of longer-term tailwinds in the business in the form of solid wins, including re-competes, add-on scope, and new wins. We are well-positioned to help our state customers with near-term priorities like the PHE unwinding and to deliver increased assessment capacity at the Federal level as well as IT modernization and transformation which represent customer priorities over the longer run."

Conference Call and Webcast Information

Maximus will host a conference call tomorrow, August 4, 2022, at 9:00 a.m. ET. Shareholders are invited to submit questions for management’s consideration by emailing IR@maximus.com up to one hour prior to the call.

The call is open to the public and available by webcast or by phone at:

877.407.8289 (Domestic) / +1.201.689.8341 (International)

For those unable to listen to the live call, a recording of the webcast will be available on investor.maximus.com.

About Maximus

As a leading strategic partner to governments across the globe, Maximus helps improve the delivery of public services amid complex technology, health, economic, environmental, and social challenges. With a deep understanding of program service delivery, acute insights that achieve operational excellence, and an extensive awareness of the needs of the people being served, our employees advance the critical missions of our partners. Maximus delivers innovative business process management, impactful consulting services, and technology solutions that provide improved outcomes for the public and higher levels of productivity and efficiency of government-sponsored programs. For more information, visit maximus.com.

Non-GAAP Measures and Risk Factors

This release refers to non-GAAP measures and other indicators, including organic growth normalized for the effects of COVID-19 response work, free cash flow, operating income and EPS adjusted for amortization of intangible assets and other non-GAAP measures.

A description of these non-GAAP measures, the reasons why we use and present them, and details as to how they are calculated are included in our earnings presentation and forthcoming Form 10-Q.

The presentation of these non-GAAP numbers is not meant to be considered in isolation, nor as alternatives to cash flows from operations, revenue growth, or net income as measures of performance. These non-GAAP financial measures, as determined and presented by us, may not be comparable to related or similarly titled measures presented by other companies.

Statements that are not historical facts, including statements about the company’s confidence and strategies, and the company’s expectations about revenues, results of operations, profitability, future contracts, market opportunities, market demand, or acceptance of the company’s products are forward-looking statements that involve risks and uncertainties.

These risks could cause the company’s actual results to differ materially from those indicated by such forward-looking statements. A summary of risk factors can be found in Item 1A, "Risk Factors" in our Annual Report on Form 10-K for the year ended September 30, 2021, which was filed with the Securities and Exchange Commission (SEC) on November 18, 2021. The company's SEC reports are accessible on maximus.com.

Maximus, Inc. Consolidated Statements of Operations (Unaudited)
	For the Three Months Ended								For the Nine Months Ended
	June 30, 2022				June 30, 2021				June 30, 2022				June 30, 2021
	(in thousands, except per share amounts)
Revenue	$	1,125,785			$	1,243,520			$	3,453,987			$	3,148,354
Cost of revenue		915,564				951,664				2,787,160				2,419,785
Gross profit		210,221				291,856				666,827				728,569
Selling, general, and administrative expenses		132,974				140,129				387,502				364,498
Amortization of intangible assets		22,690				12,132				67,951				23,718
Operating income		54,557				139,595				211,374				340,353
Interest expense		(10,791	)			(3,087	)			(29,867	)			(4,049	)
Other income/(expense), net		(2,497	)			(8,289	)			(2,093	)			(9,584	)
Income before income taxes		41,269				128,219				179,414				326,720
Provision for income taxes		9,934				33,724				44,653				87,534
Net income	$	31,335			$	94,495			$	134,761			$	239,186
Earnings per share:
Basic	$	0.51			$	1.52			$	2.17			$	3.86
Diluted	$	0.51			$	1.51			$	2.17			$	3.84
Weighted average shares outstanding:
Basic		61,607				62,064				62,038				62,028
Diluted		61,756				62,453				62,190				62,300
Dividends declared per share	$	0.28			$	0.28			$	0.84			$	0.84

Maximus, Inc. Consolidated Balance Sheets
	June 30, 2022				September 30, 2021
	(unaudited)
	(in thousands)
Assets:
Cash and cash equivalents	$	93,748			$	135,061
Accounts receivable, net		868,010				834,819
Income taxes receivable		15,608				5,413
Prepaid expenses and other current assets		94,218				104,201
Total current assets		1,071,584				1,079,494
Property and equipment, net		55,908				62,627
Capitalized software, net		48,478				42,868
Operating lease right-of-use assets		143,545				179,349
Goodwill		1,783,870				1,774,406
Intangible assets, net		829,179				879,168
Deferred contract costs, net		43,723				36,486
Deferred compensation plan assets		38,729				46,738
Deferred income taxes		4,776				990
Other assets		38,131				16,839
Total assets	$	4,057,923			$	4,118,965
Liabilities and Shareholders' Equity:
Liabilities:
Accounts payable and accrued liabilities	$	259,016			$	305,565
Accrued compensation and benefits		182,434				186,809
Deferred revenue, current portion		106,797				98,588
Income taxes payable		4,071				6,782
Long-term debt, current portion		59,698				80,555
Operating lease liabilities, current portion		67,680				76,077
Other current liabilities		50,510				35,057
Total current liabilities		730,206				789,433
Deferred revenue, non-current portion		23,518				35,932
Deferred income taxes		196,691				194,638
Long-term debt, non-current portion		1,423,276				1,429,137
Deferred compensation plan liabilities, non-current portion		39,006				47,405
Operating lease liabilities, non-current portion		93,035				121,771
Other liabilities		30,629				20,320
Total liabilities		2,536,361				2,638,636
Shareholders' equity:
Common stock, no par value; 100,000 shares authorized; 60,904 and 61,954 shares issued and outstanding as of March 31, 2022 and September 30, 2021, respectively (shares in thousands)		557,656				532,411
Accumulated other comprehensive loss		(31,991	)			(39,908	)
Retained earnings		995,897				987,826
Total shareholders' equity		1,521,562				1,480,329
Total liabilities and shareholders' equity	$	4,057,923			$	4,118,965

Maximus, Inc. Consolidated Statements of Cash Flows (Unaudited)
	For the Three Months Ended								For the Nine Months Ended
	June 30, 2022				June 30, 2021				June 30, 2022				June 30, 2021
	(in thousands)
Cash flows from operating activities:
Net income	$	31,335			$	94,495			$	134,761			$	239,186
Adjustments to reconcile net income to cash flows from operating activities:
Depreciation and amortization of property, equipment and capitalized software		8,676				10,829				29,875				33,664
Amortization of intangible assets		22,690				12,132				67,951				23,718
Amortization of debt issuance costs and debt discount		649				—				1,946				—
Costs related to debt financing		—				8,509				—				8,509
Deferred income taxes		(3,861	)			(4,319	)			(7,179	)			3,632
Stock compensation expense		7,028				7,344				22,080				20,823
Change in assets and liabilities, net of effects of business combinations
Accounts receivable		9,067				(324,521	)			(39,997	)			(254,304	)
Prepaid expenses and other current assets		(315	)			(532	)			9,454				7,542
Deferred contract costs		(1,271	)			(6,589	)			(7,702	)			(15,773	)
Accounts payable and accrued liabilities		(39,530	)			104,478				(42,577	)			116,873
Accrued compensation and benefits		42,127				51,148				13,846				34,387
Deferred revenue		(18,131	)			10,328				342				23,624
Income taxes		693				11,935				(12,822	)			15,165
Operating lease right-of-use assets and liabilities		(37	)			1,491				(1,330	)			1,077
Other assets and liabilities		(1,203	)			(9,767	)			1,128				(11,464	)
Net cash provided by/(used in) operating activities		57,917				(33,039	)			169,776				246,659
Purchases of property and equipment and capitalized software		(13,038	)			(8,549	)			(35,936	)			(32,133	)
Acquisitions of businesses, net of cash acquired		(14,140	)			(1,365,533	)			(14,144	)			(1,779,473	)
Other		2,000				—				2,000				—
Net cash used in investing activities		(25,178	)			(1,374,082	)			(48,080	)			(1,811,606	)
Cash flows from financing activities:
Cash dividends paid to Maximus shareholders		(17,103	)			(17,211	)			(51,762	)			(51,625	)
Purchases of Maximus common stock		(48,021	)			—				(73,864	)			(3,363	)
Tax withholding related to RSU vesting		—				—				(9,673	)			(9,818	)
Payments for debt financing		—				(22,759	)			—				(22,759	)
Proceeds from borrowings		175,000				1,784,838				415,000				2,285,000
Principal payments for debt		(139,265	)			(344,042	)			(442,973	)			(607,880	)
Other		—				(1	)			—				(2,763	)
Net cash (used in)/provided by financing activities		(29,389	)			1,400,825				(163,272	)			1,586,792
Effect of exchange rate changes on cash, cash equivalents, and restricted cash		(4,693	)			(433	)			(4,369	)			2,830
Net change in cash, cash equivalents, and restricted cash		(1,343	)			(6,729	)			(45,945	)			24,675
Cash, cash equivalents and restricted cash, beginning of period		111,968				119,965				156,570				88,561
Cash, cash equivalents and restricted cash, end of period	$	110,625			$	113,236			$	110,625			$	113,236

Maximus, Inc. Consolidated Results of Operations by Segment (Unaudited)
	For the Three Months Ended														For the Nine Months Ended
	June 30, 2022							June 30, 2021							June 30, 2022							June 30, 2021
	Amount				% (1)			Amount				% (1)			Amount				% (1)			Amount				% (1)
	(dollars in thousands)
Revenue:
U.S. Services	$	399,320						$	436,338						$	1,183,814						$	1,269,487
U.S. Federal Services		525,519							617,601							1,680,678							1,352,982
Outside the U.S.		200,946							189,581							589,495							525,885
Revenue	$	1,125,785						$	1,243,520						$	3,453,987						$	3,148,354
Gross Profit:
U.S. Services	$	74,135			18.6	%		$	104,814			24.0	%		$	248,805			21.0	%		$	323,256			25.5	%
U.S. Federal Services		124,203			23.6	%			155,776			25.2	%			365,932			21.8	%			312,405			23.1	%
Outside the U.S.		11,883			5.9	%			31,266			16.5	%			52,090			8.8	%			92,908			17.7	%
Gross Profit	$	210,221			18.7	%		$	291,856			23.5	%		$	666,827			19.3	%		$	728,569			23.1	%
Selling, general, and administrative expenses:
U.S. Services	$	42,351			10.6	%		$	42,606			9.8	%		$	115,726			9.8	%		$	116,655			9.2	%
U.S. Federal Services		69,466			13.2	%			69,647			11.3	%			203,340			12.1	%			172,877			12.8	%
Outside the U.S.		23,101			11.5	%			22,973			12.1	%			68,452			11.6	%			65,018			12.4	%
Other (2)		(1,944	)		NM				4,903			NM				(16	)		NM				9,948			NM
Selling, general, and administrative expenses	$	132,974			11.8	%		$	140,129			11.3	%		$	387,502			11.2	%		$	364,498			11.6	%
Operating income/(loss):
U.S. Services	$	31,784			8.0	%		$	62,208			14.3	%		$	133,079			11.2	%		$	206,601			16.3	%
U.S. Federal Services		54,737			10.4	%			86,129			13.9	%			162,592			9.7	%			139,528			10.3	%
Outside the U.S.		(11,218	)		(5.6	) %			8,293			4.4	%			(16,362	)		(2.8	) %			27,890			5.3	%
Amortization of intangible assets		(22,690	)		NM				(12,132	)		NM				(67,951	)		NM				(23,718	)		NM
Other (2)		1,944			NM				(4,903	)		NM				16			NM				(9,948	)		NM
Operating income/(loss)	$	54,557			4.8	%		$	139,595			11.2	%		$	211,374			6.1	%		$	340,353			10.8	%

(1)		Percentage of respective segment revenue. Percentages not considered meaningful are marked "NM."
(2)		Other selling, general, and administrative expenses includes costs that are not allocated to a particular segment. This includes legal expenses and settlements and expenses incurred as part of our acquisitions, as well as potential acquisitions which have not been or may not be completed. Our results for the three and nine months ended June 30, 2022 included a $2.3 million credit related to changes in acquisition related contingent consideration.

Maximus, Inc. Consolidated Free Cash Flow - Non-GAAP (Unaudited)
	For the Three Months Ended								For the Nine Months Ended
	June 30, 2022				June 30, 2021				June 30, 2022				June 30, 2021
	(in thousands)
Net cash provided by/(used in) operating activities	$	57,917			$	(33,039	)		$	169,776			$	246,659
Purchases of property and equipment and capitalized software costs		(13,038	)			(8,549	)			(35,936	)			(32,133	)
Free cash flow (Non-GAAP)	$	44,879			$	(41,588	)		$	133,840			$	214,526

Maximus, Inc. Non-GAAP Adjusted Results Excluding Amortization of Intangible Assets (Unaudited)
	For the Three Months Ended								For the Nine Months Ended
	June 30, 2022				June 30, 2021				June 30, 2022				June 30, 2021
	(dollars in thousands, except per share data)
Operating income	$	54,557			$	139,595			$	211,374			$	340,353
Add back: Amortization of intangible assets		22,690				12,132				67,951				23,718
Adjusted operating income excluding amortization of intangible assets (Non-GAAP)	$	77,247			$	151,727			$	279,325			$	364,071
Adjusted operating income margin excluding amortization of intangible assets (Non-GAAP)		6.9	%			12.2	%			8.1	%			11.6	%
Net income	$	31,335			$	94,495			$	134,761			$	239,186
Add back: Amortization of intangible assets, net of tax		16,750				8,941				50,164				17,364
Adjusted net income excluding amortization of intangible assets (Non-GAAP)	$	48,085			$	103,436			$	184,925			$	256,550
Diluted earnings per share	$	0.51			$	1.51			$	2.17			$	3.84
Add back: Effect of amortization of intangible assets on diluted earnings per share		0.27				0.15				0.80				0.28
Adjusted diluted earnings per share excluding amortization of intangible assets (Non-GAAP)	$	0.78			$	1.66			$	2.97			$	4.12

 

View source version on businesswire.com: https://www.businesswire.com/news/home/20220803006000/en/

James Francis 703.251.8526

Jessica Batt 703.251.8634

IR@maximus.com

Source: Maximus

FAQ

What were Maximus' earnings for Q3 FY2022?

Maximus reported Q3 FY2022 earnings of $0.51 per diluted share, impacted by an $11.7 million write-down.

How did COVID-19 response work affect Maximus' revenue?

Maximus' revenue decreased by $118 million, primarily due to a $413 million expected decline in COVID-19 response work.

What is the updated revenue guidance for Maximus for FY2022?

Maximus maintained its revenue guidance for FY2022 at a midpoint of $4.6 billion, with a range of $4.55 billion to $4.65 billion.

What significant contracts has Maximus secured recently?

Year-to-date, Maximus has signed contracts totaling $4.02 billion and has contracts pending totaling $476 million.

When is the next Maximus conference call scheduled?

Maximus will host a conference call on August 4, 2022, at 9:00 a.m. ET.